anticancer (Thallion/Biogen/Abbott/Eli Lilly/Centocor)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameanticancer (Thallion/Biogen/Abbott/Eli Lilly/Centocor)
Drug Alias Nameanticancer monoclonal antibodies (Thallion/Biogen/Abbott/Eli Lilly/Centocor)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThallion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesEli Lilly And CompanyBiogen Inc +[6] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A